TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Effective learning
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Interest in taking a course again
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of TNFi-naive patients who met ASAS40
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Adoption of the program
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mean glycated hemoglobin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Log-transformed RTGC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Day 7 survival
Endpoint domain: Mortality/survival
Primary endpoint: t-PA level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: ESV reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: EF improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NYHA class improvement rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: medial FN cortical thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: distal radius total BMC
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: distal radius total bone strength index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: decreased inflammatory cytokines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: A‐SICI estimates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Peak Inflating Pressure (PIP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: shorter time to clinical improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in the postanaesthesia care unit
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dual-task cost to gait speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of SC144 in sensitizing OC cells to chemotherapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absolute numbers of CD3+ lymphocytes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Level of surface PD‐1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Level of cytoplasmic AhR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Post-operative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sinus cavity's status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days abstinent from alcohol
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cholesterol transport in THP1 macrophages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Completeness of documentation in handover process
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Soluble transferrin receptor levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Retention of extinction learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in monthly number of headache days rated moderate or severe
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in monthly headache hours rated moderate or severe
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean gait speed in meters/sec
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of labour pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Increase in postpartum comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Correction of moderate or severe infraorbital hollowing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage reduction in lesion size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: patients' assessment of bleeding tendency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative noncardiac chest pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: esophageal clearance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prevalence of reflux endoscopic esophagitis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in weekly migraine days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in headache days of at least moderate severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: disengagement from care
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: time-in-care
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: social support for attending clinic appointments
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: effectiveness rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: histological improvement in the severity of NASH
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PrEP referral within 3 days of intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linkage of network members to PrEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days until first signs of granulation tissue
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days until fascial closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Three-year failure-free survival
Endpoint domain: Mortality/survival
Primary endpoint: Incidence of grade 3 to 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life scores during radiotherapy
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: mean log of rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: child compliance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: facilitative parenting
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: length of unnecessary incision
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: fixation duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Vastus medialis performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Posttreatment CA-125 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SCL-20
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normal fertilisation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: overall restoration survival rate
Endpoint domain: Mortality/survival
Primary endpoint: average adjustment time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proper fit (no adjustments)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean volume of blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvement of myocardium to extracardiac ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Number of UTIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Avoidance of the live tarantula
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of headaches per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of headache days per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neurological outcome at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Freedom from CRPC at 2 years
Endpoint domain: Mortality/survival
Primary endpoint: FEV1/FVC z‐score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Post-treatment improvements in cognitive functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of time off from work
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Efficacy of WATCHMAN FLX in reducing stroke risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rates of undetectable PSA levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Onset of placebo analgesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EQ-5D gain
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incremental cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: net monetary benefit
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Dairy fat intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Handgrip and lower limb strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fat mass and lean mass changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral self-care outcomes (OSC-P)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral self-care outcomes (OSC-S)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for oral care referrals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: cumulated leg glucose uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: leg lactate release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: leg oxygen consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage differences in treatment outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Severe IVH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Death before 28 days of life
Endpoint domain: Mortality/survival
Primary endpoint: anxiety‐potentiated startle
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FSH levels variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: LH levels variation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: estriol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Target lesion failure (TLF) rates
Endpoint domain: Mortality/survival
Primary endpoint: Bonding strength between resin and zirconia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: higher median frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: SPC counselling initiation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: peer violence victimization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peer violence perpetration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in hepatic steatosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean improvement in headache relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: requirement for rescue medication
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total gestational weight gain (GWG)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: muscle coactivation reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: highest mineral density change by μ‐CT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: smallest silver nitrate infiltration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proteolytic activity in the adhesive layer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum anxiety score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Primary patency of the fistula
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Time from administration of misoprostol to delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HIV symptom management self-efficacy
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Changes in abuse scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 1-Hydroxyphenanthrene (1-HP) concentration in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Naphthalene on skin wipes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median 25(OH)D levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Changes in immune cell composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Eczema development
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence rate of corneal transplantation after phacoemulsification
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: calf swelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade 3 or higher chemotherapy-related toxic effects
Endpoint domain: Adverse events/effects
Primary endpoint: Advance directive completion
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: %BMIp95
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Average fasting glucose level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: peak heart rate (HR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: relative maximal oxygen consumption (rVO2 max)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reactive agility performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth of compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue point time
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: restricted mean survival time
Endpoint domain: Mortality/survival
Primary endpoint: PSD in the change from baseline in ISR/G 0‐2h
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Quality of life benefits
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improving adherence to covered medications
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility of interventions
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Appropriateness of interventions
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: normalized cardiac index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: leukocytosis improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Risk of ischemic heart disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in Monthly Migraine Days (MMD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response rates at ≥50%, ≥75%, and 100% thresholds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical response to GA vs IFN‐β therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRI response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: intubation success rate
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in feelings of shame
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cardiovascular death or MI
Endpoint domain: Mortality/survival
Primary endpoint: Nonfatal MI rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: risk of subsequent cardiovascular events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Knowledge of HPV vaccination
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: mean score of diabetic neuropathy symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: severity of diabetic neuropathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: ETS (Efficacy Treatment Success)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MRTS (Mean Response Time Success) improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MoCA test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absences due to infections in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: AUROC for detecting recurrent adenoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Development of fever
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bacteremia rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Volume reduction of PTVT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Volume reduction of PTVN
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean lung dose reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PT levels in GDM patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: DMH completion rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cognition measured using MoCA
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Adverse events related to surgery
Endpoint domain: Adverse events/effects
Primary endpoint: Inhibition of FXI clotting activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Grade 3–4 treatment-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: success rate (cocaine free)
Endpoint domain: Mortality/survival
Primary endpoint: maximum surface temperature
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of child maltreatment (CM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Family quality of life
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: time to onset of complete sensory block
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sudden cardiovascular death
Endpoint domain: Mortality/survival
Primary endpoint: brachial artery flow-mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: popliteal blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: shear rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Radiological findings consistent with small bowel obstruction or internal hernia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Total radiation dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Problems in general functioning
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Prediction of ICP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TAM score of hand function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: fear of death
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: self‐management
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: ICU-free and alive days
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of translated PLSs after 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CFS score at PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SIt at PACU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes